Cargando…
In vitro high affinity α-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1
Amyloid containing deposits are a defining neuropathological feature of a wide range of dementias and movement disorders. The positron emission tomography tracer PIB (Pittsburgh Compound-B, 2-[4′-(methylamino)phenyl]-6-hydroxybenzothiazole) was developed to target senile plaques, an amyloid containi...
Autores principales: | Ye, Liang, Velasco, Ana, Fraser, Graham, Beach, Thomas G, Sue, Lucia, Osredkar, Tracy, Libri, Vincenzo, Spillantini, Maria Grazia, Goedert, Michel, Lockhart, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408655/ https://www.ncbi.nlm.nih.gov/pubmed/18221373 http://dx.doi.org/10.1111/j.1471-4159.2008.05245.x |
Ejemplares similares
-
Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)
por: Herva, Maria Eugenia, et al.
Publicado: (2014) -
Neurodegeneration and the ordered assembly of α-synuclein
por: Spillantini, Maria Grazia, et al.
Publicado: (2017) -
Postmortem Neocortical (3)H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
por: Pivtoraiko, Violetta N., et al.
Publicado: (2021) -
The Structural Combination of SIL and MODAG Scaffolds Fails to Enhance Binding to α-Synuclein but Reveals Promising Affinity to Amyloid β
por: Di Nanni, Adriana, et al.
Publicado: (2023) -
Negative (11)C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination
por: Scheinin, Noora M., et al.
Publicado: (2018)